Understanding the Challenge of Beyond-Rule-of-5 Compounds

Adv Drug Deliv Rev. 2016 Jun 1:101:1-5. doi: 10.1016/j.addr.2016.05.016.
No abstract available

Publication types

  • Editorial
  • Comment